대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)

  • 제28권3호
  • /
  • Pages.31-46
  • /
  • 2014
  • /
  • 1226-8038(pISSN)
  • /
  • 2287-9463(eISSN)
대한한방소아과학회 (The Association of Korean Oriental Pediatrics)
권호 표지
DOI QR코드

DOI QR Code

비만세포에서 연교(連翹) 추출물의 Th2 사이토카인 발현 및 신호전달 기전 억제 효과

The Suppressive Effect of Th2 Cytokines Expression and the Signal Transduction Mechanism in MC/9 Mast Cells by Forsythiae Fructus Extracts

  • 이진화 (대전대학교 한의과대학 소아과학교실) ;
  • 한재경 (대전대학교 한의과대학 소아과학교실) ;
  • 김윤희 (대전대학교 한의과대학 소아과학교실)
  • Lee, Jin Hwa (Department of Pediatrics, College of Korean Medicine, Daejeon University) ;
  • Han, Jae Kyung (Department of Pediatrics, College of Korean Medicine, Daejeon University) ;
  • Kim, Yun Hee (Department of Pediatrics, College of Korean Medicine, Daejeon University)
  • 투고 : 2014.07.24
  • 심사 : 2014.08.08
  • 발행 : 2014.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives Forsythiae Fructus treatment has been used for inflammatory and allergic diseases in Korean Medicine. Nevertheless, the mechanism of action and the cellular targets are not understood well. The pathogenesis of allergic diseases are associated with Th2 cytokines such as IL-13, MIP-$1{\alpha}$, IL-13, IL-5, GM-CSF, IL-4, TNF-${\alpha}$ and IL-6, which are secreted by the mast cells. This study was conducted to investigate the effects of Forsythiae Fructus extracts (FF) on Th2 cytokines expression and signal transduction in MC/9 mast cells. Methods In the study, MC/9 mast cells were stimulated with DNP-IgE for 24 hours and then treated separately with CsA $10{\mu}g/m{\ell}$ and varying doses of FF for one hour. MC/9 mast cells stimulated with DNP-IgE was the control group, a treatment with CsA was the positive control group and a treatment with varying doses FF was the experimental groups. The mRNA levels of IL-13, IL-5, GM-CSF, IL-4, TNF-${\alpha}$, IL-6 were analyzed with Real-time PCR. The levels of IL-13, MIP-$1{\alpha}$ were measured using enzyme-linked immunosorbent assays(ELISA). NFAT, AP-1 and NF-${\kappa}B$ p65 were examined by Western blot analysis. Results 1. FF were observed to suppress the mRNA expression of IL-13, IL-5, GM-CSF, IL-4, TNF-${\alpha}$, IL-6 in comparison to DNP-IgE control group. 2. FF also has inhibited the IL-13, MIP-$1{\alpha}$ production significantly in comparison to DNP-IgE control group. 3. Western blot analysis of transduction factors involving Th2 cytokines expression has revealed a prominent decrease of the mast cell specific transduction factors including NFAT-1, NFAT-2, c-Jun, and NF-${\kappa}B$ p65 but c-Fos. Conclusions In conclusion, the anti-allergenic activities of FF may be strongly related to the regulation of transcription factors NFAT-1, NFAT-2, c-Jun, and NF-${\kappa}B$ p65 causing inhibition of Th2 cytokines in mast cells.

키워드

참고문헌

  1. Herbology Association of Korea's Colleges of Oriental Medicine. Textbook of herbology, 1st ed. Seoul:Younglimsa. 1991:199.
  2. Ju YS. Ungok herbology. Jeonju: Woosuk Press. 2013:494-7.
  3. Wangang. Benchobeiyao. Beijing: Zhongguoyiyaokechichuban. 2012:29.
  4. Quanchuncong. Yimenzhuiyan. Wonju: Yibang medicalbooks. 2009:464.
  5. GongtingXian. Wanbinghuichun. Seoul: Bubin Publishers. 2007:50, 82.
  6. Huh J. Donguibogam. Seoul: Bubin Publishers. 2007:1997.
  7. Kim MJ, Lee SY. A literature study of atopic dermatitis for children. J Korean Orient Med. 2000;14(2):169-84.
  8. Min DL, Park EJ, Kang KH. Review of clinical and experimental studies on external application treatment for atopic dermatitis in the korean literature. J Pediatr Korean Med. 2013;27(1):36-49. https://doi.org/10.7778/jpkm.2013.27.1.036
  9. Kwon OS, Kim JT, Park IS, Ahn SH, Lee HP, Kim HH, Gang YH. The effect of Yunkyopaedosangamibang on allergic contact dermatitis : Based on the mitigation of skin damage and distributive change of mast cell on DNCB re - expasure region of mice. Dongguk J Institute Orient Med. 1999;8(1):77-91.
  10. Li ZX, Wang XH, Zhao JH, Yang JF, Wang X. Investigation on antibacterial activity of forsytjia suspense vahl in vitro with Mueller-Hinton agar. Zhongguo Zhon Yoo Zhi. 2000;25(12):742-5.
  11. Lee EB, Keum HJ. Pharmacological studies on Forsythae Fructus. Kor J Pharmacogn. 1998;19(4):262-9.
  12. Nam JB, Lee MH, Choi HY, Sohn NW, Kang H. Effect of Forsythiae Fructus ethanol extract on inflammatory cytokine production and cellular signaling pathways in mouse macrophages. Kor J Herbology. 2012;27(1):59-64. https://doi.org/10.6116/kjh.2012.27.1.59
  13. Kim SY, Park YK. Ethanol extract of Forsythiae Fructus inhibits the production of inflammatory mediators in LPS-stimulated BV-2 Microglial Cells. Kor J Herbology 2008;23(3):93-102.
  14. Lee JM, Choi SW, Cho SH, Phee SJ. Effect of Forsythia viridissima extracts on antiosidative system and lipid peroxidation of liver in rats fed high-cholesterol die. Kor J Nutr Health. 2003;36(10):990-6.
  15. Rim YS, Park MS, Kim KY, Kim MJ, Choi YH. Screening of antioxidant and antimicrobial activity in native plants. Korean J Medicinal Crop Sci. 2000;4(8):342-50.
  16. Lim DK, Choi U, Shin DH. Antioxidative activity of ethanol extract from korean medicinal plants. Korean J Food Sci Techno. 2000;8(4):342-50.
  17. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J. Inflammatory repertoire of alzheimer's disease and nondemented elderly microglia in vitro. Glia. 2001;35:72-9. https://doi.org/10.1002/glia.1072
  18. Schinella GR, Tournier HA, Prieto JM, Modujovich D, Rios JL. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 2002;70:1023-33. https://doi.org/10.1016/S0024-3205(01)01482-5
  19. Kim MJ, Kim JY, Jung TK, Choi SW, Yoon KS. Skin anti-aging effect of Forsythia Vridissima L. extract. Korean J Botechnol Bioeng. 2006;21(6):444-50.
  20. Yoon JY, Han JK, Kim YH. Effect of Kami-chungsimyeunjatang on atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation. J Korean Oriental Pediatrics. 2007;21(1):87-116.
  21. Park SK, Han JK, Kim YH. Anti-dermatitis effects of Kamichengsimyeonjatang on GATA-3 regulation in NC/Nga mouse. J Pediatr Korean Med. 2009;23(2):29-50.
  22. Song HJ, Han JK, Kim YH. Effects of Kakamsodokum (KKSDU) on atopic dermatitis-like skin lesions in NC/Nga mouse. J Pediatr Korean Med. 2009;23(1):23-35.
  23. Shin DG, Kim WY, Lee JY, Kim DK. Effect of Sunbangpaedoktang on the cytokine secretory function of monocyte isolated and cultured from peripheral blood of AD patients. J Pediatr Korean Med. 2002;16(1):13-82.
  24. Kim WY, Lee JY. Effects of Hanghaedan on the cytokine secretory function of monocytes of atopic dermatitis patients. J Pediatr Korean Med. 2007;21(2):169-84.
  25. Park YM. Advances in the pathophysiology of atopic dermatitis. J Pediatr Allergy Respir Dis (Korea). 2006;16(3):189-96.
  26. Ahn HS. Hongchangui pediatrics 9th edition. Seoul:Miraen. 2010:1142.
  27. Park Y. Moisturizers in atopic dermatitis. J Skin Barrier Research (Korean). 2007;9(1):37-40.
  28. Kim JW. Atopic dermatitis at allergic and immunological aspects. J Korean Dermatol Assoc. 2003;41(6):687-9.
  29. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol. 1992;99(4):403-8. https://doi.org/10.1111/1523-1747.ep12616114
  30. Valent P, Spanbloochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992;80(9):2237-45.
  31. Ahn SG, Pack BD, Won JH, Sung YY, Cheon SH. Atopic dermatitis for the opening doctor. Seoul: Pacific Publisher Co. 2007:13-82.
  32. Munetaka I, Yoko M, Kazumi S, Yosuke O, Keiyu U. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997;44(7):1299-305. https://doi.org/10.1016/S0039-9140(97)00017-9
  33. Greer FR, Sicherer SH, Burks AW. Effect of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008;111:608-16.
  34. Van der Hulst AE, Klip H, Brand PI. Risk of developing asthma in young children with atopic eczema; a systemic review. J Allegy Clin Immunol. 2007;120:565-9. https://doi.org/10.1016/j.jaci.2007.05.042
  35. Mosmann TR, Coffman RI. Th1 and Th2 cells; Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73. https://doi.org/10.1146/annurev.iy.07.040189.001045
  36. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther. 2002;94(3):253-624. https://doi.org/10.1016/S0163-7258(02)00220-6
  37. Gibbs BF, Haas H, Wolff HH, Grabbe J. Early IgE-dependent release of IL-4 and IL-13 from leukocytes is restricted to basophils : a comparison with other granulocytes and mononuclear cells. Inflamm Res. 2000;49(1):9-10. https://doi.org/10.1007/PL00000197
  38. Kim JT. Evaluation of inflammation in childhood asthma; Non-invasive measurement. J Korean Pediatr Soc. 2001;44(3):334-9.
  39. Weber A, Knop J, Maurer M. Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol. 2003;148(2):224-8. https://doi.org/10.1046/j.1365-2133.2003.05090.x
  40. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G. High-affinity IgE receptor(Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996;153:1931-7. https://doi.org/10.1164/ajrccm.153.6.8665058
  41. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol. 1998;102(3):491-502. https://doi.org/10.1016/S0091-6749(98)70140-X
  42. Matsubara M, Masaki S, Ohmori K, Karasawa A, Hasegawa K. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol. 2004;67(7):1315-26. https://doi.org/10.1016/j.bcp.2003.12.008
  43. Kou X, Qi S, Dai W, Luo D, Yin Z. Arctigenin inhibits lipopolysaccharide -induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway. Int Immunopharmacol. 2011;11(8):1095-102. https://doi.org/10.1016/j.intimp.2011.03.005
  44. Jang HH. Effects of arctigenin on nitric oxide production in human umbilical vein endothelial cells. Grad School Chonnam Univ. 2010.
  45. Lee JY, Kim CJ. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes. Arch Pharm Res. 2010;33(6):947-57. https://doi.org/10.1007/s12272-010-0619-1
  46. Park JH, Hong YJ, Moon EJ, Kim SA, Kim SY. Forsythiae Fructus and its active component, arctigenin, provide neuroprotection by inhibiting neuroinflammation. Biomol Ther (Seoul). 2011;19(4):425-30. https://doi.org/10.4062/biomolther.2011.19.4.425
  47. Lee DJ, Shim SS. Effect of arctigenin on tyrosinase activity and melanin production in B16 melanoma cells. J Pharm Soc Korea. 2012;56(6):395-400.
  48. Lee IS, Nguyen Tien Dat, Cai XF, Shen GG, Kim YH. Inhibitory effects of natural products against NFAT(nuclear factor of activated T cells) transcription factor. Kor J Phamacogn. 2003;34(2):150-5.
  49. Lewin I, Nechushtan H, Ke Q, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 1993;82(12):3745-51.
  50. D'Acquisto F, May MJ, Ghosh S. Inhibition of Nuclear Factor Kappa B(NF-$\kappa{B}$) : An emerging theme in anti-inflammatory therapies. Mol Interv. 2002;2(1):22-35. https://doi.org/10.1124/mi.2.1.22
  51. Park GY, Lee SH, Hwangbo B, Im JJ, Lee CT, Kim YH, Han SG, Sim YS, Yu CG. Pro-inflammatory cytokine expression through NF-$\kappa{B}$/$I\kappa{B}$ pathway in lung epithelial cells. Tuberc Respir Dis. 2000;49(3):332-42. https://doi.org/10.4046/trd.2000.49.3.332

피인용 문헌

  1. 연교(連翹) n-BuOH 분획물의 아토피 피부염 억제 효과 vol.30, pp.3, 2014, https://doi.org/10.7778/jpkm.2016.30.3.001